Skip to content

Clinical trials

Phase 3 Breast Neoplasms trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Phase 3 Country / region: Norway Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20052
20072
20081
20091
20111
20124
20131
20142
20151
20161
20215
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting4
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Hoffmann-La Roche6
AstraZeneca4
Pfizer2
AbbVie1
Cancer Trials Ireland1
Genentech, Inc.1
GlaxoSmithKline1
Merck Sharp & Dohme LLC1
Region Örebro County1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms28
Neoplasms4
Breast Diseases3
Neoplasm Metastasis3
Neoplasms by Site3
Triple Negative Breast Neoplasms2
Brain Neoplasms1
Breast Carcinoma In Situ1
Hereditary Sensory and Autonomic Neuropathies1
Multiple Endocrine Neoplasia Type 11

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.